ALHC Alignment Healthcare
- 13.160
- -0.300-2.23%
- 13.060
- -0.100-0.76%
Alignment Healthcare News
TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $13
Piper Sandler Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $14
Alignment Healthcare Analyst Ratings
A Quick Look at Today's Ratings for Alignment Healthcare(ALHC.US), With a Forecast Between $8 to $14
Alignment Healthcare Is Maintained at Neutral by UBS
UBS Maintains Neutral on Alignment Healthcare, Raises Price Target to $12
Barclays Maintains Alignment Healthcare(ALHC.US) With Sell Rating, Raises Target Price to $8
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $14
William Blair Initiates Alignment Healthcare(ALHC.US) With Buy Rating
Alignment Healthcare Analyst Ratings
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Maintains Target Price $14
Stifel Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $14
Buy Rating Affirmed for Alignment Healthcare on Strong Growth and Operational Efficiency Prospects Into 2025
Alignment Healthcare Analyst Ratings
Baird Maintains Outperform on Alignment Healthcare, Raises Price Target to $11
Alignment Healthcare Price Target Raised to $10.00/Share From $8.00 by TD Cowen
Piper Sandler Reiterates Overweight on Alignment Healthcare, Raises Price Target to $10
TD Cowen Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $10
Piper Sandler Maintains Alignment Healthcare(ALHC.US) With Buy Rating, Raises Target Price to $10
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Alignment Healthcare (ALHC) and Akoya Biosciences (AKYA)
Analysis
Price Target
No Data
No Data